Effects of multispecies probiotic combination on Helicobacter pylori infection in vitro

Clinical and Vaccine Immunology

Volumn 15, Issue 9, 2008, Pages

  Myllyluoma, E ^a,b   Ahonen, A M ^c   Korpela, R ^a,b,c   Vapaatalo, H ^a   Kankuri, E ^a,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FOUNDATION FOR NUTRITION RESEARCH   (Finland)

^c VALIO LTD   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; INTERLEUKIN 10; INTERLEUKIN 8; LACTATE DEHYDROGENASE; LEUKOTRIENE B4; PROBIOTIC AGENT; PROSTAGLANDIN E2;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BIFIDOBACTERIUM BREVE; CELL STRAIN CACO 2; CONTROLLED STUDY; ENZYME ACTIVATION; HELICOBACTER INFECTION; IMMUNOFLUORESCENCE; INFLAMMATION; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM FREUDENREICHII;

APOPTOSIS; BACTERIAL ADHESION; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; CACO-2 CELLS; CASPASE 3; CELL MEMBRANE PERMEABILITY; CYTOKINES; FLUORESCENT ANTIBODY TECHNIQUE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; L-LACTATE DEHYDROGENASE; LACTOBACILLUS; PROBIOTICS; PROPIONIBACTERIUM;

EID: 51649083010     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00080-08     Document Type: Article

References (57)

1. Bai, A. P., Q. Ouyang, W. Zhang, C. H. Wang, and S. F. Li. 2004. Probiotics inhibit TNF-α-induced interleukin-8 secretion of HT29 cells. World J. Gastroenterol. 10:455-457.
2. Bernet, M. F., D. Brassart, J. R. Neeser, and A. L. Servin. 1993. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl. Environ. Microbiol. 59:4121-4128.
3. Bizik, J., E. Kankuri, A. Ristimäki, A. Taieb, H. Vapaatalo, W. Lubitz, and A. Vaheri. 2004. Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression. Cell Death Differ. 11:183-195.
4. Blum, S., Y. Delneste, S. Alvarez, D. Haller, P. F. Perez, C. Bode, W. P. Hammes, A. M. A. Pfeifer, and E. J. Schiffrin. 1999. Interactions between commensal bacteria and mucosal immunocompetent cells. Int. Dairy J. 9:63-68.
5. Bodger, K., and J. E. Crabtree. 1998. Helicobacter pylori and gastric inflammation. Br. Med. Bull. 54:139-150.
6. Coconnier, M. H., V. Lievin, E. Hemery, and A. L. Servin. 1998. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Environ. Microbiol. 64:4573-4580.
7. Dunn, B. E., H. Cohen, and M. J. Blaser. 1997. Helicobacter pylori. Clin. Microbiol. Rev. 10:720-741.
8. Elo, S., M. Saxelin, and S. Salminen. 1991. Attachment of Lactobacillus casei strain GG to human colon carcinoma cell line Caco-2: comparison with other dairy strains. Lett. Appl. Microbiol. 13:154-156.
9. Eurogast Study Group. 1993. An international association between Helicobacter pylori infection and gastric cancer. Lancet 341:1359-1362.
10. Felley, C., and P. Michetti. 2003. Probiotics and Helicobacter pylori. Best Pract. Res. Clin. Gastroenterol. 17:785-791.
11. Forestier, C., C. De Champs, C. Vatoux, and B. Joly. 2001. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res. Microbiol. 152:167-173.
12. Fox, J. G., and T. C. Wang. 2001. Helicobacter pylori - not a good bug after all. N. Engl. J. Med. 345:829-832.
13. Gionchetti, P., F. Rizzello, U. Helwig, A. Venturi, K. M. Lammers, P. Brigidi, B. Vitali, G. Poggioli, M. Miglioli, and M. Campieri. 2003. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124:1202-1209.
14. Hamilton-Miller, J. M. 2003. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int. J. Antimicrob. Agents 22:360-366.
15. Hart, A. L., K. Lammers, P. Brigidi, P. Vitali, F. Rizzello, P. Gionchetti, M. Campieri, M. A. Kamm, S. C. Knight, and A. J. Stagg. 2004. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53:1602-1609.
16. Hidalgo, I. J., T. J. Raub, and R. T. Borchardt. 1989. Characterization of the human colon carcinoma cell line (Caco-2) as model system for intestinal epithelial permeability. Gastroenterology 96:736-749.
17. IARC. 1994. Schistosomes, liver flukes and Helicobacter pylori, p. 1-241. Monographs on the evaluation of carcinogenic risks to humans. IARC Science, Lyon, France.
18. Isolauri, E., P. V. Kirjavainen, and S. Salminen. 2002. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 50(Suppl. iii): 54-59.
19. Jan, G., A. S. Belzacq, D. Haouzi, A. Rouault, D. Metivier, G. Kroemer, and C. Brenner. 2002. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ. 9:179-188.
20. Joint FAO/WHO Working Group. 2002. Report on drafting guidelines for the evaluation of probiotics in food. FAO and WHO, London, Ontario, Canada.
21. Kajander, K., K. Hatakka, T. Poussa, M. Färkkilä, and R. Korpela. 2005. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment. Pharmacol. Ther. 22:387-394.
22. Kankuri, E., D. Cholujova, M. Comajova, A. Vaheri, and J. Bizik. 2005. Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res. 65:9914-9922.
23. Kim, J. M., J. S. Kim, H. C. Jung, I. S. Song, and C. Y. Kim. 2002. Up-regulation of inducible nitric oxide synthase and nitric oxide in Helicobacter pylori-infected human gastric epithelial cells: possible role of interfer-on-gamma in polarized nitric oxide secretion. Helicobacter 7:116-128.
24. Korhonen, R., O. Kosonen, R. Korpela, and E. Moilanen. 2004. The expression of COX-2 protein induced by Lactobacillus rhamnosus GG, endotoxin and lipoteichoic acid in T84 epithelial cells. Lett. Appl. Microbiol. 39:19-24.
25. Lammers, M., U. Helwig, E. Swennen, F. Rizzello, A. Venturi, E. Caramelli, M. A. Kamm, P. Brigidi, P. Gionchetti, and M. Campieri. 2002. Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am. J. Gastroenterol. 97:1182-1186.
26. Lorca, G. L., T. Wadström, G. F. Valdez, and Å. Ljungh. 2001. Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr. Microbiol. 42:39-44.
27. Ma, D., P. Forsythe, and J. Bienenstock. 2004. Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect. Immun. 72:5308-5314.
28. Marshall, B. J., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i:1311-1315.
29. McCracken, V. J., T. Chun, M. E. Baldeón, S. Ahrné, G. Molin, R. I. Mackie, and H. R. Gaskins. 2002. TNF-α sensitizes HT-29 colonic epithelial cells to intestinal lactobacilli. Exp. Biol. Med. 227:665-670.
30. Menard, S., C. Candalh, J. C. Bambou, K. Terpend, N. Cerf-Bensussan, and M. Heyman. 2004. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53:821-828.
31. Midolo, P. D., J. R. Lambert, R. Hull, F. Luo, and M. L. Grayson. 1995. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J. Appl. Bacteriol. 79:475-479.
32. Mimura, T., F. Rizzello, U. Helwig, G. Poggioli, S. Schreiber, I. C. Talbot, R. J. Nicholls, P. Gionchetti, M. Campieri, and M. A. Kamm. 2004. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53:108-114.
33. Morita, H., F. He, T. Fuse, A. C. Ouwehand, H. Hashimoto, M. Hosoda, K. Mizumachi, and J. I. Kurisaki. 2002. Adhesion of lactic acid bacteria to Caco-2 cells and their effect on cytokine secretion. Microbiol. Immunol. 46:293-297.
34. Mukai, T., T. Asasaka, E. Sato, K. Mori, M. Matsumoto, and H. Ohori. 2002. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol. Med. Microbiol. 32:105-110.
35. Mumy, K. L., and B. A. McCormick. 2004. Events at the host-microbial interface of the gastrointestinal tract. II. Role of the intestinal epithelium in pathogen-induced inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 288:G854-G859.
36. Myllyluoma, E., L. Veijola, T. Ahlroos, S. Tynkkynen, E. Kankuri, H. Vapaatalo, H. Rautelin, and R. Korpela. 2005. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy - a placebo-controlled, double-blind randomized pilot study. Aliment. Pharmacol. Ther. 21:1263-1272.
37. Nam, H., M. Ha, O. Bae, and Y. Lee. 2002. Effect of Weissella confusa strain PL9001 on the adherence and growth of Helicobacter pylori. Appl. Environ. Microbiol. 68:4642-4645.
38. Naumann, M., and J. Crabtree. 2004. Helicobacter pylori-induced epithelial cell signaling in gastric carcinogenesis. Trends Microbiol. 12:29-36.
39. Nozawa, Y., K. Nishihara, R. M. Peek, M. Nakano, T. Uji, H. Ajioka, N. Matsura, and H. Miyake. 2002. Identification of a signalling cascade for interleukin-8 production by Helicobacter pylori in human gastric epithelial cells. Biochem. Pharmacol. 64:21-30.
40. Otte, J. M., and D. K. Podolsky. 2004. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am. J. Physiol. Gastrointest. Liver Physiol. 286:G613-G626.
41. Pai, R., T. L. Cover, and A. S. Tarnawski. 1999. Helicobacter pylori vacuolating cytotoxin (VacA) disorganizes the cytoskeletal architecture of gastric epithelial cells. Biochem. Biophys. Res. Commun. 262:245-250.
42. Papini, E., B. Satin, N. Norais, M. de Bernard, J. L. Telford, and R. Rappuoli. 1998. Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J. Clin. Investig. 102:813-820.
43. Pelicic, V., J. M. Reyrat, L. Sartori, C. Pagliaccia, R. Rappuoli, J. L. Telford, C. Montecucco, and E. Papini. 1999. Helicobacter pylori VacA cytotoxin associated with the bacteria increases epithelial permeability independently of its vacuolating activity. Microbiology 145:2043-2050.
44. Peña, J. A., and J. Versalovic. 2003. Lactobacillus rhamnosus GG decreases TNF-α production in lipopolysaccharide- activated murine macrophages by a contact-independent mechanism. Cell. Microbiol. 5:277-285.
45. Pohjavuori, E., M. Viljanen, R. Korpela, M. Kuitunen, M. Tiittanen, O. Vaarala, and E. Savilahti. 2004. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J. Allergy Clin. Immunol. 114:131-136.
46. Servin, A. L. 2004. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol. Rev. 28:405-440.
47. Servin, A. L., and M. H. Coconnier. 2003. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract. Res. Clin. Gastroenterol. 17:741-754.
48. Sgouras, D., P. Maragkoudakis, K. Petraki, B. Martinez-Gonzalez, E. Eriotou, S. Michopoulos, G. Kalantzopoulos, E. Tsakalidou, and A. Mentis. 2004. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl. Environ. Microbiol. 70:518-526.
49. Smoot, D. T., Z. Wynn, T. B. Elliott, C. R. Allen, G. Mekasha, T. Naab, and H. Ashktorab. 1999. Effects of Helicobacter pylori on proliferation of gastric epithelial cells in vitro. Am. J. Gastroenterol. 94:1508-1511.
50. Terrés, A. M., J. M. Pajares, A. M. Hopkins, A. Murphy, A. Moran, A. W. Baird, and D. Kelleher. 1998. Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators. Infect. Immun. 66:2943-2950.
51. Tsai, C. C., L. F. Huang, C. C. Lin, and H. Y. Tsen. 2004. Antagonistic activity against Helicobacter pylori infection in vitro by a strain of Enterococcus faecium TM39. Int. J. Food Microbiol. 96:1-12.
52. Tuomola, E. M., and S. J. Salminen. 1998. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int. J. Food Microbiol. 41:45-51.
53. Tuomola, E. M., A. C. Ouwehand, and S. J. Salminen. 1999. The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunol. Med. Microbiol. 26:137-142.
54. Vedamuthu, E. R., M. Raccach, B. A. Glatz, E. W. Seitz, and M. S. Reddy. 1992. Acid producing microorganism, p. 225-238. In C. Vanderzant and D. F. Splittstoesser (ed.), Compendium of methods for the microbiological examination of foods. APHA. Washington, DC.
55. Viljanen, M., E. Pohjavuori, T. Haahtela, R. Korpela, M. Kuitunen, A. Sarnesto, O. Vaarala, and E. Savilahti. 2005. Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J. Allergy Clin. Immunol. 115:1254-1259.
56. Viljanen, M., M. Kuitunen, T. Haahtela, K. Juntunen-Backman, R. Korpela, and E. Savilahti. 2005. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr. Allergy Immunol. 16:65-71.
57. Yan, F., and B. Polk. 2002. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J. Biol. Chem. 277:50959-50965.